SRNE - Sorrento Therapeutics: COVISTIX Will Support The Growth
- Sorrento Therapeutics released its Q3-2021 results.
- COVISTIX received "CE" Mark and approval for marketing in Belgium.
- Brazilian authority approved the use of COVISTIX in the Country.
For further details see:
Sorrento Therapeutics: COVISTIX Will Support The Growth